Dr. Pozos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Midtown Doctor's Building, Suite 700
2545 Chicago Avenue South
Minneapolis, MN 55404Phone+1 651-220-6444Fax+1 651-220-7233
Education & Training
- University of WashingtonFellowship, Pediatric Infectious Diseases, 2002 - 2006
- University of California (San Francisco)Residency, Pediatrics, 1998 - 2002
- Stanford University School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 2000 - Present
- MN State Medical License 2008 - 2025
- WA State Medical License 2002 - 2008
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Registry Study of Revcovi Treatment in Patients With ADA-SCID Start of enrollment: 2019 Sep 30
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Ther...Morna J Dorsey, Manish J Butte, Jay A Lieberman, Heather Lehman, Tracy Fausnight
Journal of Clinical Immunology. 2025-03-27 - Improvement in Atopic Dermatitis and Recurrent Infection With Dupilumab in Children With Distinct Genetic Types of Hyper-IgE Syndrome: A Case Series and Literature Rev...Jenna K Dick, Christina Boull, Tamara C Pozos, Sheilagh M Maguiness
Pediatric Dermatology. 2024-10-18 - Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies.Niraj C Patel, Troy Torgerson, Monica S Thakar, M Elizabeth M Younger, Panida Sriaroon
Journal of Clinical Immunology. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: